Should we consider cancer/testis antigens NY-ESO-1, MAGE-A4 and MAGE-A1 as potential targets for immunotherapy in vulvar squamous cell carcinoma?

Histopathology. 2011 Feb;58(3):481-3. doi: 10.1111/j.1365-2559.2011.03772.x. Epub 2011 Feb 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antigens, Neoplasm / metabolism*
  • Carcinoma, Squamous Cell / immunology*
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / therapy
  • Female
  • Humans
  • Immunotherapy
  • Male
  • Membrane Proteins / antagonists & inhibitors
  • Membrane Proteins / metabolism*
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / metabolism*
  • Peptide Fragments / antagonists & inhibitors
  • Peptide Fragments / metabolism*
  • Vulvar Neoplasms / immunology*
  • Vulvar Neoplasms / pathology
  • Vulvar Neoplasms / therapy

Substances

  • Antigens, Neoplasm
  • CTAG1B protein, human
  • MAGE-A1 protein (278-286), human
  • MAGEA4 protein, human
  • Membrane Proteins
  • Neoplasm Proteins
  • Peptide Fragments